Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release

Statin drugs inhibit 3-hydroxy-3-methylglutaryl CoA reductase, which reduces the synthesis of both cholesterol and isoprenoids (geranylgeranyl pyrophosphate and farnesyl pyrophosphate), with the latter being lipid molecules responsible for the posttranslational modification of small GTP-binding prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2013-03, Vol.304 (5), p.H660
Hauptverfasser: Clapp, K M, Ellsworth, M L, Sprague, R S, Stephenson, A H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page H660
container_title American journal of physiology. Heart and circulatory physiology
container_volume 304
creator Clapp, K M
Ellsworth, M L
Sprague, R S
Stephenson, A H
description Statin drugs inhibit 3-hydroxy-3-methylglutaryl CoA reductase, which reduces the synthesis of both cholesterol and isoprenoids (geranylgeranyl pyrophosphate and farnesyl pyrophosphate), with the latter being lipid molecules responsible for the posttranslational modification of small GTP-binding proteins such as Rho. Effects of statins, independent of lowering blood cholesterol levels, are thought to occur by inhibition of Rho/Rho kinase. The Rho kinase inhibitor Y-27632 has been reported to increase both erythrocyte deformability and low ... tension-induced ATP release. Here, we tested the hypothesis that by inhibiting Rho/Rho kinase, simvastatin would increase both erythrocyte deformability and low ... tension-induced ATP release. Male Sprague-Dawley rats were divided into two groups, control or simvastatin treated [simvastatin-supplemented chow (0.02%)], for 4 wk. Simvastatin treatment increased rat erythrocyte deformability compared with controls (n = 6, P < 0.05). However, erythrocytes of simvastatin-treated rats (n = 9, P < 0.05) exhibited impaired low ... tension-induced ATP release. Similarly, the geranylgeranyl transferase inhibitor GGTI-2133 (10 ?M) also increased deformability and impaired low ... tension-induced ATP release in healthy human erythrocytes (P < 0.05). Interestingly, ATP release in response to mastoparan 7 (n = 7, P < 0.05), which directly activates Gi, and isoproterenol (n = 5, P < 0.05), which signals through Gs, was not altered by incubation with GGTI-2133. These results suggest that although statins increase erythrocyte deformability, likely by inhibiting geranylgeranylation, the finding that both statins and a geranylgeranyl transferase inhibitor attenuated low ... tension-induced ATP release demonstrates that factors in addition to erythrocyte deformability are critical for ATP release in response to this physiological stimulus. (ProQuest: ... denotes formulae/symbols omitted.)
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1314408308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2907016111</sourcerecordid><originalsourceid>FETCH-proquest_journals_13144083083</originalsourceid><addsrcrecordid>eNqNjN1KAzEQhUNR6PrzDgPeNpBsutt6KaLVqwrudUt2d9ampIkmE2Ufxbc1C30A4cA3Z87hzFghq7LkslL3F6wQqla8lqqas6sYj0KIalWrgv2-m9O3jqTJONCuh82meeWlVGoBGj4waDfaM4Ay4pBNRDDuYFpDPizy2QWcfhhGOgTfjYTQ4-DDSbfGGhqhTQQB-9QhWP8D211MLZQ7IHTReMeNm7IeHpq33LPT2g27HLSNeHvmNbt7fmoeX_hn8F8JI-2PPgWXo71UcrkUa5X1v9Yf91pahg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1314408308</pqid></control><display><type>article</type><title>Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release</title><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Clapp, K M ; Ellsworth, M L ; Sprague, R S ; Stephenson, A H</creator><creatorcontrib>Clapp, K M ; Ellsworth, M L ; Sprague, R S ; Stephenson, A H</creatorcontrib><description>Statin drugs inhibit 3-hydroxy-3-methylglutaryl CoA reductase, which reduces the synthesis of both cholesterol and isoprenoids (geranylgeranyl pyrophosphate and farnesyl pyrophosphate), with the latter being lipid molecules responsible for the posttranslational modification of small GTP-binding proteins such as Rho. Effects of statins, independent of lowering blood cholesterol levels, are thought to occur by inhibition of Rho/Rho kinase. The Rho kinase inhibitor Y-27632 has been reported to increase both erythrocyte deformability and low ... tension-induced ATP release. Here, we tested the hypothesis that by inhibiting Rho/Rho kinase, simvastatin would increase both erythrocyte deformability and low ... tension-induced ATP release. Male Sprague-Dawley rats were divided into two groups, control or simvastatin treated [simvastatin-supplemented chow (0.02%)], for 4 wk. Simvastatin treatment increased rat erythrocyte deformability compared with controls (n = 6, P &lt; 0.05). However, erythrocytes of simvastatin-treated rats (n = 9, P &lt; 0.05) exhibited impaired low ... tension-induced ATP release. Similarly, the geranylgeranyl transferase inhibitor GGTI-2133 (10 ?M) also increased deformability and impaired low ... tension-induced ATP release in healthy human erythrocytes (P &lt; 0.05). Interestingly, ATP release in response to mastoparan 7 (n = 7, P &lt; 0.05), which directly activates Gi, and isoproterenol (n = 5, P &lt; 0.05), which signals through Gs, was not altered by incubation with GGTI-2133. These results suggest that although statins increase erythrocyte deformability, likely by inhibiting geranylgeranylation, the finding that both statins and a geranylgeranyl transferase inhibitor attenuated low ... tension-induced ATP release demonstrates that factors in addition to erythrocyte deformability are critical for ATP release in response to this physiological stimulus. (ProQuest: ... denotes formulae/symbols omitted.)</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>Bethesda: American Physiological Society</publisher><subject>Adenosine triphosphatase ; Erythrocytes ; Protease inhibitors ; Rodents ; Statins</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2013-03, Vol.304 (5), p.H660</ispartof><rights>Copyright American Physiological Society Mar 1, 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Clapp, K M</creatorcontrib><creatorcontrib>Ellsworth, M L</creatorcontrib><creatorcontrib>Sprague, R S</creatorcontrib><creatorcontrib>Stephenson, A H</creatorcontrib><title>Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release</title><title>American journal of physiology. Heart and circulatory physiology</title><description>Statin drugs inhibit 3-hydroxy-3-methylglutaryl CoA reductase, which reduces the synthesis of both cholesterol and isoprenoids (geranylgeranyl pyrophosphate and farnesyl pyrophosphate), with the latter being lipid molecules responsible for the posttranslational modification of small GTP-binding proteins such as Rho. Effects of statins, independent of lowering blood cholesterol levels, are thought to occur by inhibition of Rho/Rho kinase. The Rho kinase inhibitor Y-27632 has been reported to increase both erythrocyte deformability and low ... tension-induced ATP release. Here, we tested the hypothesis that by inhibiting Rho/Rho kinase, simvastatin would increase both erythrocyte deformability and low ... tension-induced ATP release. Male Sprague-Dawley rats were divided into two groups, control or simvastatin treated [simvastatin-supplemented chow (0.02%)], for 4 wk. Simvastatin treatment increased rat erythrocyte deformability compared with controls (n = 6, P &lt; 0.05). However, erythrocytes of simvastatin-treated rats (n = 9, P &lt; 0.05) exhibited impaired low ... tension-induced ATP release. Similarly, the geranylgeranyl transferase inhibitor GGTI-2133 (10 ?M) also increased deformability and impaired low ... tension-induced ATP release in healthy human erythrocytes (P &lt; 0.05). Interestingly, ATP release in response to mastoparan 7 (n = 7, P &lt; 0.05), which directly activates Gi, and isoproterenol (n = 5, P &lt; 0.05), which signals through Gs, was not altered by incubation with GGTI-2133. These results suggest that although statins increase erythrocyte deformability, likely by inhibiting geranylgeranylation, the finding that both statins and a geranylgeranyl transferase inhibitor attenuated low ... tension-induced ATP release demonstrates that factors in addition to erythrocyte deformability are critical for ATP release in response to this physiological stimulus. (ProQuest: ... denotes formulae/symbols omitted.)</description><subject>Adenosine triphosphatase</subject><subject>Erythrocytes</subject><subject>Protease inhibitors</subject><subject>Rodents</subject><subject>Statins</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNjN1KAzEQhUNR6PrzDgPeNpBsutt6KaLVqwrudUt2d9ampIkmE2Ufxbc1C30A4cA3Z87hzFghq7LkslL3F6wQqla8lqqas6sYj0KIalWrgv2-m9O3jqTJONCuh82meeWlVGoBGj4waDfaM4Ay4pBNRDDuYFpDPizy2QWcfhhGOgTfjYTQ4-DDSbfGGhqhTQQB-9QhWP8D211MLZQ7IHTReMeNm7IeHpq33LPT2g27HLSNeHvmNbt7fmoeX_hn8F8JI-2PPgWXo71UcrkUa5X1v9Yf91pahg</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Clapp, K M</creator><creator>Ellsworth, M L</creator><creator>Sprague, R S</creator><creator>Stephenson, A H</creator><general>American Physiological Society</general><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20130301</creationdate><title>Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release</title><author>Clapp, K M ; Ellsworth, M L ; Sprague, R S ; Stephenson, A H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_13144083083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adenosine triphosphatase</topic><topic>Erythrocytes</topic><topic>Protease inhibitors</topic><topic>Rodents</topic><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clapp, K M</creatorcontrib><creatorcontrib>Ellsworth, M L</creatorcontrib><creatorcontrib>Sprague, R S</creatorcontrib><creatorcontrib>Stephenson, A H</creatorcontrib><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clapp, K M</au><au>Ellsworth, M L</au><au>Sprague, R S</au><au>Stephenson, A H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><date>2013-03-01</date><risdate>2013</risdate><volume>304</volume><issue>5</issue><spage>H660</spage><pages>H660-</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>Statin drugs inhibit 3-hydroxy-3-methylglutaryl CoA reductase, which reduces the synthesis of both cholesterol and isoprenoids (geranylgeranyl pyrophosphate and farnesyl pyrophosphate), with the latter being lipid molecules responsible for the posttranslational modification of small GTP-binding proteins such as Rho. Effects of statins, independent of lowering blood cholesterol levels, are thought to occur by inhibition of Rho/Rho kinase. The Rho kinase inhibitor Y-27632 has been reported to increase both erythrocyte deformability and low ... tension-induced ATP release. Here, we tested the hypothesis that by inhibiting Rho/Rho kinase, simvastatin would increase both erythrocyte deformability and low ... tension-induced ATP release. Male Sprague-Dawley rats were divided into two groups, control or simvastatin treated [simvastatin-supplemented chow (0.02%)], for 4 wk. Simvastatin treatment increased rat erythrocyte deformability compared with controls (n = 6, P &lt; 0.05). However, erythrocytes of simvastatin-treated rats (n = 9, P &lt; 0.05) exhibited impaired low ... tension-induced ATP release. Similarly, the geranylgeranyl transferase inhibitor GGTI-2133 (10 ?M) also increased deformability and impaired low ... tension-induced ATP release in healthy human erythrocytes (P &lt; 0.05). Interestingly, ATP release in response to mastoparan 7 (n = 7, P &lt; 0.05), which directly activates Gi, and isoproterenol (n = 5, P &lt; 0.05), which signals through Gs, was not altered by incubation with GGTI-2133. These results suggest that although statins increase erythrocyte deformability, likely by inhibiting geranylgeranylation, the finding that both statins and a geranylgeranyl transferase inhibitor attenuated low ... tension-induced ATP release demonstrates that factors in addition to erythrocyte deformability are critical for ATP release in response to this physiological stimulus. (ProQuest: ... denotes formulae/symbols omitted.)</abstract><cop>Bethesda</cop><pub>American Physiological Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2013-03, Vol.304 (5), p.H660
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_journals_1314408308
source American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adenosine triphosphatase
Erythrocytes
Protease inhibitors
Rodents
Statins
title Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O^sub 2^ tension-induced ATP release
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A38%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Simvastatin%20and%20GGTI-2133,%20a%20geranylgeranyl%20transferase%20inhibitor,%20increase%20erythrocyte%20deformability%20but%20reduce%20low%20O%5Esub%202%5E%20tension-induced%20ATP%20release&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Clapp,%20K%20M&rft.date=2013-03-01&rft.volume=304&rft.issue=5&rft.spage=H660&rft.pages=H660-&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/&rft_dat=%3Cproquest%3E2907016111%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1314408308&rft_id=info:pmid/&rfr_iscdi=true